Cytosorbents Corp expected to post a loss of 90 cents a share - Earnings Preview

Cytosorbents

10/11/2026 22:33

Cytosorbents Corp CTSO.OQ CTSO.O is expected to  show a rise in quarterly revenue when it reports  results on November 12 for the period ending September 30 2026
The Princeton New Jersey-based  company is expected to report a 4.5% increase in revenue to $9.915 million from $9.49 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data.
​LSEG's mean analyst estimate for Cytosorbents Corp is for a loss of 90 cents per share. 
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for Cytosorbents Corp is $15.00, about 157.3% above its last closing price of $5.83
Previous quarterly performance (using preferred earnings measure in US dollars). ​
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE 
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Jun. 30 2026
-0.80
-0.90
-1.40
Missed
-55.6
Mar. 31 2026
-1.20
-1.10
-1.60
Missed
-45.5
Dec. 31 2025
-0.90
-1.00
-1.80
Missed
-80​
Sep. 30 2025
-0.60
-0.93
-1.00
Missed
-7.1
​​Jun. 30 2025
-0.84
-1.00
0.60
Beat
160
Mar. 31 2025
-1.43
-1.40
-0.40
Beat
71.4​
Dec. 31 2024
-1.20
-1.27
-2.80
Missed
-121.1
Sep. 30 2024
-1.23
-1.27
-0.80
Beat
36.8
This summary was machine generated November 10 at 22:33 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)